Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May;35(5):771-785.
doi: 10.1007/s10552-023-01838-0. Epub 2024 Jan 4.

Lymphedema self-assessment among endometrial cancer survivors

Affiliations

Lymphedema self-assessment among endometrial cancer survivors

Jordyn A Brown et al. Cancer Causes Control. 2024 May.

Abstract

Purpose: Lower extremity lymphedema (LEL), which causes ankle, leg, and feet swelling, poses a significant challenge for endometrial cancer survivors, impacting physical functioning and psychological well-being. Inconsistent LEL diagnostic methods result in wide-ranging LEL incidence estimates.

Methods: We calculated the cumulative incidence of LEL based on survivor-reported Gynecologic Cancer Lymphedema Questionnaire (GCLQ) responses in addition to survivor- and nurse-reported leg circumference measurements among a pilot sample of 50 endometrial cancer survivors (27 White, 23 Black) enrolled in the ongoing population-based Carolina Endometrial Cancer Study.

Results: Self-leg circumference measurements were perceived to be difficult and were completed by only 17 survivors. Diagnostic accuracy testing measures (sensitivity, specificity, positive and negative predictive value) compared the standard nurse-measured 10% difference in leg circumference measurements to GCLQ responses. At a mean of ~11 months post-diagnosis, 54% of survivors met established criteria for LEL based on 4 GCLQ cutpoint while 24% had LEL based on nurse-measurement. Percent agreement, sensitivity, and specificity approximated 60% at a threshold of 5 GCLQ symptoms. However, Cohen's kappa, a measure of reliability that corrects for agreement by chance, was highest at 4 GCLQ symptoms (κ = 0.27).

Conclusion: Our findings emphasize the need for high quality measurements of LEL that are feasible for epidemiologic study designs among endometrial cancer survivors. Future studies should use patient-reported survey measures to assess lymphedema burden and quality of life outcomes among endometrial cancer survivors.

Keywords: Cancer survivorship; Endometrial neoplasm; Lymphedema; Uterine neoplasm.

PubMed Disclaimer

Conflict of interest statement

Competing interests The authors report no potential or actual competing interests.

Figures

Fig. 1
Fig. 1
Flow chart of study sample selection including endometrial cancer survivor recruitment, exclusion criteria, and refusals into Carolina Endometrial Cancer Study home visit pilot
Fig. 2
Fig. 2
Leg circumference measurement worksheet used by pilot participants and nurse-interviewer
Fig. 3
Fig. 3
Survivor feedback about the level of difficulty among survivors who submitted self-measured lower extremity leg circumference measurements

Similar articles

Cited by

References

    1. Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73:17–48. 10.3322/caac.21763 - DOI - PubMed
    1. National Cancer Institute. Cancer Stat Facts: Uterine Cancer. [Internet]. Accessed June 16 (2023) Accessed at: https://seer.cancer.gov/statfacts/html/corp.html
    1. Clarke MA, Devesa SS, Hammer A, Wentzensen N (2022) Racial and ethnic differences in hysterectomy-corrected uterine Corpus Cancer Mortality by Stage and histologic subtype. JAMA Oncol 8:895–903. 10.1001/jamaoncol.2022.0009 - DOI - PMC - PubMed
    1. Saris DH, Smith AJB, Brensinger C et al. (2022) Disparities in cancer-specific and overall survival in black women with endometrial cancer: a Medicare-SEER study. Gynecologic Oncol Rep 40:100922. 10.1016/j.gore.2022.100922 - DOI - PMC - PubMed
    1. National Cancer Institute Surveillance Epidemiology and End Results Program SEER*Explorer: An interactive website for SEER cancer statistics. [Internet]. Accessed August 1 (2023) Accessed at: https://seer.cancer.gov/statistics-network/explorer/

Publication types